{
  "company": {
    "name": "Hansa Biopharma",
    "website": "https://hansabiopharma.com/",
    "record": "https://startuphistory.org/c/hansabiopharma.com"
  },
  "status": null,
  "history_since": "2020-07-12T03:28:47.000Z",
  "baseline": {
    "snapshot_id": "401e0a9273e1e293668c2d26bde4c261a2a645904cc49b734a6b8813f28dbd13",
    "observed_at": "2020-07-12T03:28:47.000Z",
    "headline": null,
    "description": "Hansa Biopharma are leveraging cutting-edge science to develop lifesaving and life altering therapies for patients with rare immunological diseases.",
    "evidence": "https://web.archive.org/web/20200712032847/https://hansabiopharma.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:16:07.975Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-02-04T22:44:15.000Z",
      "variants": [
        {
          "headline": "Addressing urgent unmet needs in rare diseases",
          "subhead": "We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
          "observed_at": "2023-09-23T10:47:54.000Z",
          "evidence": "https://web.archive.org/web/20230923104754/https://www.hansabiopharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Addressing urgent unmet needs in rare diseases",
          "subhead": "We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
          "observed_at": "2024-02-04T22:44:15.000Z",
          "evidence": "https://web.archive.org/web/20240204224415/https://www.hansabiopharma.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Addressing urgent unmet needs in rare diseases",
      "subhead": "We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
      "from": "2023-09-23T10:47:54.000Z",
      "to": "2024-02-04T22:44:15.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20240204224415/https://www.hansabiopharma.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-09-23T10:47:54.000Z",
          "to": "2024-02-04T22:44:15.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:16:07.975Z",
      "variants": [
        {
          "headline": "Empowering people living with rare immunologic diseases",
          "subhead": "We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
          "observed_at": "2026-09-11T07:31:06.000Z",
          "evidence": "https://web.archive.org/web/20260911073106/https://www.hansabiopharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Empowering people living with rare immunologic diseases",
          "subhead": "We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
          "observed_at": "2026-11-06T17:16:07.975Z",
          "evidence": "https://www.hansabiopharma.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Empowering people living with rare immunologic diseases",
      "subhead": "We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.",
      "from": "2026-09-11T07:31:06.000Z",
      "to": "2026-11-06T17:16:07.975Z",
      "captures": 2,
      "evidence": "https://www.hansabiopharma.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-09-11T07:31:06.000Z",
          "to": "2026-11-06T17:16:07.975Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-bef6d949050f358fdde0c2105912ff9616e3cc408f181b6552c70f72a7c15a2d:79723745e1772e3129a805ababce4bc5ad1c17c16db9d3c1a1e0965213a9b909:headline:408edfa8648d6a5a",
      "before_evidence": "https://web.archive.org/web/20220811171655/https://www.hansabiopharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Our Why” to “Addressing urgent unmet needs in rare diseases”.",
      "between": {
        "from": "2022-08-11T17:16:55.000Z",
        "to": "2023-09-23T10:47:54.000Z"
      },
      "evidence": "https://web.archive.org/web/20230923104754/https://www.hansabiopharma.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Hansa Biopharma” company record, https://startuphistory.org/c/hansabiopharma.com"
}